Comparison between Goyal Salt IPO and Saakshi Medtech IPO.
Goyal Salt IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Saakshi Medtech IPO is a SME Bookbuilding proposed to list at NSE SME.
| Goyal Salt IPO | Saakshi Medtech IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Holani Consultants Pvt.Ltd. | Hem Securities Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Holani Consultants Pvt.Ltd. | Hem Finlease Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Goyal Salt IPO is up to ₹17.69 Cr whereas the issue size of the Saakshi Medtech IPO is up to ₹42.88 Cr. The final issue price of Goyal Salt IPO is ₹38.00 per share and of Saakshi Medtech IPO is ₹97.00 per share.
| Goyal Salt IPO | Saakshi Medtech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹36.00 per share | ₹92.00 per share |
| Issue Price (Upper) | ₹38.00 per share | ₹97.00 per share |
| Issue Price (Final) | ₹38.00 per share | ₹97.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 3000 shares | 1200 shares |
| Fresh Issue Size | 46,56,000 shares | 44,20,800 shares |
| Fresh Issue Size (Amount) | up to ₹17.69 Cr | up to ₹42.88 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 46,56,000 shares | 44,20,800 shares |
| Issue Size Total (Amount) | up to ₹17.69 Cr | up to ₹42.88 Cr |
Goyal Salt IPO opens on Sep 26, 2023, while Saakshi Medtech IPO opens on Sep 25, 2023. The closing date of Goyal Salt IPO and Saakshi Medtech IPO is Oct 03, 2023, and Sep 27, 2023, respectively.
| Goyal Salt IPO | Saakshi Medtech IPO | |
|---|---|---|
| Anchor Bid Date | Sep 25, 2023 | Sep 22, 2023 |
| Issue Open | Sep 26, 2023 | Sep 25, 2023 |
| Issue Close | Oct 03, 2023 | Sep 27, 2023 |
| Basis Of Allotment (Tentative) | Oct 05, 2023 | Oct 03, 2023 |
| Initiation of Refunds (Tentative) | Oct 06, 2023 | Oct 04, 2023 |
| Credit of Share (Tentative) | Oct 09, 2023 | Oct 05, 2023 |
| Listing date (Tentative) | Oct 11, 2023 | Oct 03, 2023 |
| Anchor Lockin End date 1 | Nov 04, 2023 | Nov 02, 2023 |
| Anchor Lockin End date 2 | Jan 03, 2024 | Jan 01, 2024 |
Goyal Salt IPO P/E ratio is 13.97, as compared to Saakshi Medtech IPO P/E ratio of 10.18.
| Goyal Salt IPO | Saakshi Medtech IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Standalone)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.63 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 13.97 | 10.18 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹68.02 Cr. | ₹171.26 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 25.38% | 34.35% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 36.22% | 28.57% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.57 | 0.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.72 | ₹9.53 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 21.86% | 29.32% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Goyal Salt IPO Retail Individual Investors (RII) are offered 16,38,000 shares while in Saakshi Medtech IPO retail investors are offered 16,38,000 shares. Qualified Institutional Buyers (QIB) are offered 8,82,000 shares in Goyal Salt IPO and 8,84,400 shares in Saakshi Medtech IPO.
| Goyal Salt IPO | Saakshi Medtech IPO | |
|---|---|---|
| Anchor Investor Reservation | 13,17,000 shares | 13,24,800 shares |
| Market Maker Reservation | 2,46,000 shares | 2,35,200 shares |
| QIB | 8,82,000 shares | 8,84,400 shares |
| NII | 7,29,000 shares | 6,63,600 shares |
| RII | 16,38,000 shares | 15,48,000 shares |
| Employee | 90,000 shares | |
| Others | ||
| Total | 46,56,000 shares | 44,20,800 shares |
Goyal Salt IPO subscribed 294.61x in total, whereas Saakshi Medtech IPO subscribed 91.65x.
| Goyal Salt IPO | Saakshi Medtech IPO | |
|---|---|---|
| QIB (times) | 67.20x | 37.35x |
| NII (times) | 382.45x | 200.78x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 377.97x | 75.88x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 294.61x | 91.65x |
